AAAAAA

   
Results: 1-11 |
Results: 11
TNF-ALPHA AS A GROWTH-FACTOR IN THE MYELODYSPLASTIC SYNDROMES
Authors: PREISLER HD BURKE P KOTELNIKOV V FANNING S GAO XZ VENUGOPAL P
Citation: Hd. Preisler et al., TNF-ALPHA AS A GROWTH-FACTOR IN THE MYELODYSPLASTIC SYNDROMES, Cancer research, therapy & control, 5(4), 1998, pp. 329-336
FLOW-CYTOMETRIC - PRINCIPLES AND FEASIBILITY IN TRANSFUSION MEDICINE - ENUMERATION OF EPITHELIAL DERIVED TUMOR-CELLS IN PERIPHERAL-BLOOD
Authors: TERSTAPPEN LWMM RAO C GROSS S KOTELNIKOV V RACILLA E UHR J WEISS A
Citation: Lwmm. Terstappen et al., FLOW-CYTOMETRIC - PRINCIPLES AND FEASIBILITY IN TRANSFUSION MEDICINE - ENUMERATION OF EPITHELIAL DERIVED TUMOR-CELLS IN PERIPHERAL-BLOOD, Vox sanguinis, 74, 1998, pp. 269-274
ACCURACY OF HISTONE H3 MESSENGER-RNA IN-SITU HYBRIDIZATION FOR THE ASSESSMENT OF CELL-PROLIFERATION IN HUMAN TISSUES
Authors: KOTELNIKOV V CASS L COON JS SPAULDING D PREISLER HD
Citation: V. Kotelnikov et al., ACCURACY OF HISTONE H3 MESSENGER-RNA IN-SITU HYBRIDIZATION FOR THE ASSESSMENT OF CELL-PROLIFERATION IN HUMAN TISSUES, Clinical cancer research, 3(5), 1997, pp. 669-673
MUTATION OF P53 IN SQUAMOUS-CELL CANCER OF THE HEAD AND NECK - RELATIONSHIP TO TUMOR-CELL PROLIFERATION
Authors: WOOD NB KOTELNIKOV V CALDARELLI DD HUTCHINSON J PANJE WR HEDGE P LEURGANS S LAFOLLETTE S TAYLOR SG PREISLER HD COON JS
Citation: Nb. Wood et al., MUTATION OF P53 IN SQUAMOUS-CELL CANCER OF THE HEAD AND NECK - RELATIONSHIP TO TUMOR-CELL PROLIFERATION, The Laryngoscope, 107(6), 1997, pp. 827-833
EQUIVALENCE OF HISTONE H3 IN-SITU HYBRIDIZATION (HHISH) AND INTRAVENOUS ADMINISTRATION OF IUDR BRDU FOR ESTIMATING THE PERCENT OF S-PHASE CELLS IN NON-HODGKINS-LYMPHOMA (NHL)/
Authors: CHOPRA HK VENUGOPAL P KOTELNIKOV V SIVARAMAN S RILEY MB MEYER P LOEW J GREGORY SA RAZA A PREISLER HD
Citation: Hk. Chopra et al., EQUIVALENCE OF HISTONE H3 IN-SITU HYBRIDIZATION (HHISH) AND INTRAVENOUS ADMINISTRATION OF IUDR BRDU FOR ESTIMATING THE PERCENT OF S-PHASE CELLS IN NON-HODGKINS-LYMPHOMA (NHL)/, Blood, 90(10), 1997, pp. 3814-3814
EFFECTS OF 13 CIS-RETINOIC ACID AND ALPHA-INTERFERON (RA IFN) ON CML CELLS IN-VIVO - DIFFERENCES BETWEEN B3A2 AND B2A2 CML/
Authors: PREISLER HD GAO XZ HANDA H HEGDE U KOTELNIKOV V RAZA A
Citation: Hd. Preisler et al., EFFECTS OF 13 CIS-RETINOIC ACID AND ALPHA-INTERFERON (RA IFN) ON CML CELLS IN-VIVO - DIFFERENCES BETWEEN B3A2 AND B2A2 CML/, Experimental hematology, 24(9), 1996, pp. 591-591
CHRONIC MYELOGENOUS LEUKEMIAS ASSOCIATED WITH B3A2 AND B2A2 BCR ABL MESSENGER-RNAS ARE BIOLOGICALLY DIFFERENT/
Authors: GAO XZ HANDA H BI S KOTELNIKOV V ROSE S PREISLER HD
Citation: Xz. Gao et al., CHRONIC MYELOGENOUS LEUKEMIAS ASSOCIATED WITH B3A2 AND B2A2 BCR ABL MESSENGER-RNAS ARE BIOLOGICALLY DIFFERENT/, Blood, 88(10), 1996, pp. 2282-2282
IMMUNOSTIMULATING INFLUENCE OF POLYBIOLIN ON FUNCTIONAL-ACTIVITY OF PERIPHERAL-BLOOD NEUTROPHILS
Authors: NOVOSAD AB KOZINETZ G KOTELNIKOV V DUTKA R NEVSGODA A NOVOSAD AM KOROTKY V
Citation: Ab. Novosad et al., IMMUNOSTIMULATING INFLUENCE OF POLYBIOLIN ON FUNCTIONAL-ACTIVITY OF PERIPHERAL-BLOOD NEUTROPHILS, Experimental hematology, 23(8), 1995, pp. 774-774
INHIBITION OF REGROWTH RESISTANCE AND EARLY CYTOGENETIC RESPONSES IN THE MYELOGENOUS LEUKEMIA
Authors: PREISLER HD RAZA A GEZER S HSU WT GREGORY S ADLER S LARSON R RIFKIN S SHOWEL J KOTELNIKOV V CHANEY C
Citation: Hd. Preisler et al., INHIBITION OF REGROWTH RESISTANCE AND EARLY CYTOGENETIC RESPONSES IN THE MYELOGENOUS LEUKEMIA, Blood, 86(10), 1995, pp. 2107-2107
EFFECTS OF 13-CIS RETINOIC ACID AND ALPHA-INTERFERON (RA IFN) ON CML CELLS IN-VIVO IN PATIENTS
Authors: HANDA H HEGDE U KOTELNIKOV V MUNDLE S RAZA A PRESTIFILLIPO J PREISLER HD
Citation: H. Handa et al., EFFECTS OF 13-CIS RETINOIC ACID AND ALPHA-INTERFERON (RA IFN) ON CML CELLS IN-VIVO IN PATIENTS, Blood, 84(10), 1994, pp. 10000152-10000152
A STRATEGY OVERCOMING REGROWTH RESISTANCE IN CHRONIC MYELOGENOUS LEUKEMIA (SORRCML)
Authors: PREISLER HD KOTELNIKOV V HEGDE U MONSON K GREGORY S ADLER S MCKENNA R PRESTIFILIPPO JA MONEER Y
Citation: Hd. Preisler et al., A STRATEGY OVERCOMING REGROWTH RESISTANCE IN CHRONIC MYELOGENOUS LEUKEMIA (SORRCML), Blood, 82(10), 1993, pp. 10000556-10000556
Risultati: 1-11 |